KRC Inc. MANAGEMENT & MARKETING IN PHARMACEUTICAL INDUSTRY

Contact Us

Session 1	INTRODUCTION
Session 2	PHARMACEUTICAL PROJECT STRATEGY
Session 3	DEVELOPMENT STRATEGY FOR PHARMACEUTICAL PROJECT
Session 4	Pharmaceutical Industry Overview
Session 5	Pre-clinical Research  Pre-Clinical Studies of Drug / Product Candidates
Session 6	Phases of Clinical Trials
Session 7	Investigational New Drug Application (I.N.D.) in USA  and New Drug Submission (NDS) in Canada
Session 8	Good Clinical Practice & International Conference on Harmonisation
Session 9	TARGET PRODUCT PROFILE - CASE STUDY FOR IMAGINARY DRUG  REUMALYSINE
Session 10	DRUG DEVELOPMENT AS A BUSINESS
Session 11	Portfolio Level : Strategic Pharmaceutical Project Management
Session 12	PHARMACEUTICAL PROJECT PLANNING
Session 13	OVERVIEW OF OTHER INDUSTRIES: BEST PRACTICES AND EXPERIENCE
Session 14	International Pharmaceutical Project TEAM Management
Session 15	Managing Joint Pharmaceutical Projects
Session 16	outsourcing:   CONTRACT RESEARCH ORGANIZATIONS (CRO)
Session 17	MANAGEMENT OF DRUG DELIVERY DEVICES DEVELOPMENT PROJECTS
Session 18	MANAGEMENT OF CLINICAL TRIAL PROJECTS
Session 19	MANUFACTURING PROJECT MANAGEMENT
Session 20	INTRODUCING CHANGE INTO RESEARCH AND  DEVELOPMENT ORGANIZATION
Session 21	Pharmaceutical Project  Management IN Information Technology Era
Session 22	General Principles OF MARKETING IN PHARMACEUTICAL INDUSTRY
Session 23	General Environment FOR PHARMACEUTICAL MARKETING
Session 24	General Practices IN PHARMACEUTICAL MARKETING
Session 25	pharmaceutical marketing:  Product Research and Development
Session 26	Pharmaceutical Industry AND Its External Environment
Session 27	PHARMACEUTICAL MARKETING: ACTS AND REGULATIONS
Session 28	PRICING  IN PHARMACEUTICAL INDUSTRY
Session 29	Principles of Place, Channel Systems, and Channel Specialists
Session 30	PROMOTION PRINCIPLES
SESSION 31	PATIENT NEEDS
Session 32	Introduction to Six Sigma
Session 33	GENERAL PRINCIPLES OF PHARMACOLOGY
Session 34	PRINCIPLES OF PHARMACODYNAMICS, TRANSDUCTION AND NEUROTRANSMISSION
Session 35	KINETIC PRINCIPLES OF DRUG ADMINISTRATION (Pharmacokinetic)
Session 36	DRUG INTERACTIONS AND METABOLISM
Session 37	DRUGS ACTING ON THE SYMPATHETIC NERVOUS SYSTEM (ADRENERGIC DRUGS)
Session 38	ANTIBIOTICS
Session 39	DRUGS AFFECTING THE COAGULATION SYSTEM
Session 40	DRUGS USED IN TREATMENT OF ALLERGIES
Session 41	TREATMENT OF CENTRAL NERVOUS SYSTEM DEGENERATIVE DISORDERS
Session 42	DRUGS FOR THE TREATMENT OF VIRAL DISEASES
Session 43	CHEMOTHERAPY OF NEOPLASTIC DISEASES
Session 44	DRUGS ACTING ON THE PARASYMPATHETIC NERVOUS SYSTEM (CHOLINERGIC DRUGS)
Session 45	DRUGS USED IN DERMATOLOGY
Session 46	CARDIAC GLYCOSIDES, ANTIARRHYTHICS AND DRUGS, USED IN ISCHEMIC HEART DISEASE
Session 47	HORMONES, VITAMINS, AND MINERALS.
Session 48	HYPOTENSIVE DRUGS AND LIPIDS-LOWERING DRUGS
Session 49	OPIOID DRUGS
Session 50	NSAIDs - NONSTEROIDAL ANTIINFLAMMATORY DRUGS
Session 51	HIPAA
PROJECT I	Prolipostat Project
PROJECT II	EGF Project
PROJECT III	PU CR Project
PROJECT IV	ISTA Project
Submit the Article	Submission of Industry Related Article to International Biopharmaceutical Association Publications and/or other Industry Publications
Final Exam	http://training.krigertraining.net/MM/proceed_to_mm_exam.htm
Resume Help	Resume Help Session

 

INTERNATIONAL REGULATORY MODULE

Read Student's testimonials

Privacy Policy - Terms of Use

Copyright Kriger Research Center Inc. 2003